CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment

BACKGROUND: Bone is the predominant site of metastasis from breast cancer, and recent trials have demonstrated that adjuvant bisphosphonate therapy can reduce bone metastasis development and improve survival. There is an unmet need for prognostic and predictive biomarkers so that therapy can be appr...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Natl Cancer Inst
Prif Awduron: Westbrook, Jules A., Cairns, David A., Peng, Jianhe, Speirs, Valerie, Hanby, Andrew M., Holen, Ingunn, Wood, Steven L., Ottewell, Penelope D., Marshall, Helen, Banks, Rosamonde E., Selby, Peter J., Coleman, Robert E., Brown, Janet E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4808632/
https://ncbi.nlm.nih.gov/pubmed/26757732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv360
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg